Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.1994 USD
−13.21 M USD
0.00 USD
20.12 M
About ProMIS Neurosciences Inc.
Sector
Industry
CEO
Neil K. Warma
Website
Headquarters
Toronto
Founded
2004
FIGI
BBG000R0MF47
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PMN is 0.9600 USD — it has decreased by −10.64% in the past 24 hours. Watch ProMIS Neurosciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ProMIS Neurosciences Inc. stocks are traded under the ticker PMN.
PMN stock has fallen by −8.00% compared to the previous week, the month change is a −6.48% fall, over the last year ProMIS Neurosciences Inc. has showed a −25.58% decrease.
We've gathered analysts' opinions on ProMIS Neurosciences Inc. future price: according to them, PMN price has a max estimate of 9.50 USD and a min estimate of 8.00 USD. Watch PMN chart and read a more detailed ProMIS Neurosciences Inc. stock forecast: see what analysts think of ProMIS Neurosciences Inc. and suggest that you do with its stocks.
PMN stock is 5.21% volatile and has beta coefficient of 1.30. Track ProMIS Neurosciences Inc. stock price on the chart and check out the list of the most volatile stocks — is ProMIS Neurosciences Inc. there?
Today ProMIS Neurosciences Inc. has the market capitalization of 27.49 M, it has decreased by −2.55% over the last week.
Yes, you can track ProMIS Neurosciences Inc. financials in yearly and quarterly reports right on TradingView.
ProMIS Neurosciences Inc. is going to release the next earnings report on Mar 14, 2025. Keep track of upcoming events with our Earnings Calendar.
PMN earnings for the last quarter are 0.31 USD per share, whereas the estimation was −0.07 USD resulting in a 553.88% surprise. The estimated earnings for the next quarter are −0.16 USD per share. See more details about ProMIS Neurosciences Inc. earnings.
PMN net income for the last quarter is 9.28 M USD, while the quarter before that showed −2.62 M USD of net income which accounts for 453.55% change. Track more ProMIS Neurosciences Inc. financial stats to get the full picture.
No, PMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 26, 2024, the company has 7.00 employees. See our rating of the largest employees — is ProMIS Neurosciences Inc. on this list?
Like other stocks, PMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ProMIS Neurosciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ProMIS Neurosciences Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ProMIS Neurosciences Inc. stock shows the sell signal. See more of ProMIS Neurosciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.